相关实验视频

Updated: Jun 1, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

达沙提尼布诱导的妇产不适:一个病例报告

Himanshi Kaushik¹, Kanchan D Devde¹, Nishtha Manuja²

¹Medical Oncology, Jawaharlal Nehru Medical College, Wardha, IND.

|January 22, 2025

概括

达沙替尼 (Dasatinib) 是一种白血病药物,很少会导致妇产不良 (男性乳腺扩大). 本病例报告详细介绍了一名患有这种副作用的患者,强调需要对其机制和管理进行监测和进一步研究.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
药理学药理学是指药理学的学科.

背景情况:

妇产不良,男性乳腺组织的异常扩大,是达沙替尼的罕见副作用.
达沙替尼 (Dasatinib) 是一种用于慢性髓性白血病 (CML) 的氨酸激酶抑制剂.

研究的目的:

在CML患者中报告达沙提尼布诱导的妇产不适病例.
讨论这种罕见的副作用的潜在机制,临床表现和管理.

主要方法:

一个52岁的男性患有CML,在达沙替尼治疗四个月后经历了双边乳房扩大和疼痛的病例介绍.
在正常范围内评估荷尔蒙特征 (,雌激素,益生菌,FSH).

主要成果:

在达沙替尼治疗期间,患者出现了与妇产不良一致的症状.
荷尔蒙水平正常,表明非荷尔蒙机制或复杂的相互作用.

结论:

达沙提尼布诱导的妇产不良是一种罕见但可能的不良反应.
潜在的机制涉及达沙替尼的激酶抑制;需要进一步研究.
监测患者并教育他们关于潜在的荷尔蒙异常至关重要.

关键词:

爆炸细胞的爆炸细胞.骨髓的吸收骨髓的吸收慢性骨髓性白血病慢性骨髓性白血病测试剂测试剂测试剂测试剂氨酸激酶抑制剂氨酸激酶抑制剂

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...